Article and Video CATEGORIES
Dr. Ravi Salgia from University of Chicago explains his approach to management of acquired resistance to a targeted therapy for advanced NSCLC, both in the setting of a single area of progression and also when disease progression is more diffuse.
[powerpress]
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
It is so good to hear from you, and my sentiments are the same as Janine's. You are definitely why we do this, and we truly appreciate your kind words. Happiest...
Stan, thanks so much for sending this very kind note. It is because of people like you and Sara that we are so tirelessly dedicated to our mission of helping to...
Hi and welcome to GRACE. I'm sorry mother is experiencing oligoprogrssion. This often happens when some of the cancer cells acquire a resistance to alecensa's effects. Those cells can be radiated...
help Mom to continue using Alectinib. Thank you for the video list as well. Is there any experience or some period in which SBRT works, is it individual or are there...
Oh yes! SBRT (Stereotactic body radiation therapy) is a very focused type of radiation that is able to target and kill the tumor without the destruction of healthy tissue. The goal...
Hi again, thank you very much for the detailed response. I hope that SBRT will help my mom and that she will use Alecensa for a long time and after Alecensa...
Hi Stan! It's good to see you. I can only imagine what this last year has been like for you and hope the grieving is getting more manageable every day. GRACE...